{"url_path":"/sec/vnrx/8-k/2026-07-21/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/93314/0001477932-26-004421-index.html","accession_number":"0001477932-26-004421","cik":"0000093314","ticker":"VNRX","issuer_name":"VOLITIONRX LTD","edgar_url":"https://www.sec.gov/Archives/edgar/data/93314/0001477932-26-004421-index.html","primary_entity_key":"0000093314","primary_entity_name":"VOLITIONRX LTD"},"word_count":183,"has_tables":true,"body_markdown":"**Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.**\n\n \n\nOn July 17, 2026, VolitionRx Limited (the “Company”) filed a Certificate of Fourth Amendment (the “Amendment”) of the Second Amended and Restated Certificate of Incorporation (as amended, the “Restated Certificate”) with the Secretary of State of the State of Delaware, which became effective upon filing. The Amendment amends Section 6.1 of the Restated Certificate to reduce the number of authorized shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), from 325,000,000 to 150,000,000.\n\n \n\nThe Amendment had previously been approved by the board of directors of the Company (the “Board”) on May 11, 2026, subject to the approval of the Company’s stockholders. The Amendment was approved by the Company’s stockholders at the Annual Meeting (as defined below) as described in Item 5.07 below.\n\n \n\nThe foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is filed as Exhibit 3.1 hereto and is incorporated herein by reference."}